Alandag Celal
- 17 anos de experiência
- Localização: Turquia, Sivas
Compare os principais médicos e preços de Quimioterapia para cancro da próstata em Turquia. Encontre o seu melhor par aqui.
Vamos selecionar os melhores médicos com base nas suas necessidades e orçamento.
Revisado por Fahad Mawlood
Editor médico e cientista de dadosMelhores médicos
2
Turquia
Avaliações
14000+
De pacientes reais
Compare os preços de Quimioterapia para cancro da próstata entre os principais países
Toque em um país para ver os principais médicos e preços
Receba planos de tratamento personalizados gratuitos e escolha a melhor opção. Sem compromisso · Sem pagamentos pelos nossos serviços
Escolher clínica no exterior pode ser estressante. No Bookimed, com mais de 800K pacientes atendidos, entendemos preocupações. Sabemos encontrar médicos confiáveis, melhores opções de custo-benefício e soluções até para casos complexos. Estamos aqui para orientar em cada etapa.
Yan Matsiivskiy
Chefe da Equipe de Coordenadores Médicos
4300++ jornadas de pacientes acompanhadas
3 anos na Bookimed
278 pacientes de Turkey encontraram seu médico conosco este mês
Quiz de 2 minutos
Conte-nos seu objetivo, orçamento e prazo
Combinação Humana + IA
Nosso algoritmo encontra correspondências, o coordenador verifica a adequação
Suas opções prontas
Compare preços, pacotes, datas. Converse com seu coordenador
Muitas opções?
Orientando seu tratamento
Coordenadores pessoais com formação médica






| Classificação | Médico | experiência | Bom para | O que os diferencia | Clínica e localização | Consulta |
|---|
Top medical oncologists in Turkey for prostate cancer hold certifications from the European Society for Medical Oncology (ESMO). Specialists like Dr. Mustafa Solak and Dr. Yesim Yildirim treat advanced cases at JCI-accredited centers. These doctors often have training from MD Anderson or Rambam Medical Center.
Bookimed Expert Insight: Data shows a high concentration of urological cancer specialists at Anadolu Medical Center. Dr. Eda Tanrikulu ranked 3rd in Turkey's national oncology exam, highlighting the competitive academic rigor. Patients can access consultations with these experts starting from $100 to around $215.
Patient Consensus: Patients note that getting a second opinion on pathology is vital before starting chemotherapy. They appreciate oncologists who are direct about side effects like fatigue or neuropathy. Many felt more confident when their doctor personally managed complex sequencing for metastatic cases.
Turkish prostate cancer specialists must hold a Medical Oncology Specialty License after completing a specific internal medicine residency and a three-year oncology fellowship. Look for professors with ESMO certification and international training from institutions like MD Anderson or Cleveland Clinic.
Bookimed Expert Insight: Data shows that leading Turkish oncologists often hold dual certifications and international research background. For instance, Dr. Yesim Yildirim and Dr. Seref Komurcu are both ESMO-certified with over 20 years of experience. Dr. Cemil Bilir and Dr. Mustafa Solak gained expertise at prestigious US institutions like the Cleveland Clinic and MD Anderson, offering patients access to global treatment protocols in Istanbul.
Patient Consensus: Patients note it is important to find an oncologist who explains hormone and chemotherapy sequencing in plain language. Many emphasize choosing a specialist at hospitals with tumor boards to ensure all doctors coordinate the treatment plan together. Families often feel relieved when the doctor has specific experience managing side effects for advanced cancer cases.
Turkey's top specialists in prostate cancer chemotherapy practice at JCI-accredited centers in Istanbul and Antalya. These institutions feature multidisciplinary tumor boards and ESMO-certified departments. Leading oncologists hold fellowships from institutions like MD Anderson and the Cleveland Clinic to manage complex systemic treatments.
Bookimed Expert Insight: Data shows a strong trend of international training among Turkey's medical oncology leaders. For instance, Dr. Mustafa Solak and Dr. Cemil Bilir trained at top-tier US institutions like MD Anderson and the Cleveland Clinic. This exposure allows them to implement the latest global chemotherapy sequencing for aggressive, castration-resistant cases.
Patient Consensus: Patients emphasize that successful treatment depends on choosing hospitals with in-house PSMA PET-CT and pathology labs. They note that having all diagnostics under one roof prevents delays in starting chemotherapy cycles. Many were relieved to find that major centers provide English-speaking coordinators to explain each step of the plan.